Bill115th CongressFiled Jul 28, 2017Health
H.R. 3536
To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Jul 28, 2017)
This bill prohibits federal agencies and nonprofit entities that conduct federally funded health care research from providing a patent for a drug based on such research until the entity receiving the patent enters into a reasonable pricing agreement with the Department of Health and Human Services.
What just happenedAug 4, 2017
Referred to the Subcommittee on Health.
Who’s behind it
Rep. DeFazio, Peter A. [D-OR-4](D-OR)Sponsor
7 cosponsors7 D
7cosponsors1committees4actions1related bills7subjects
- Introduced in HouseJul 28, 2017
- Aug 4, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 28, 2017IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jul 28, 2017IntroReferralIntro-H
Introduced in House
- Jul 28, 2017IntroReferral1000
Introduced in House